Home » Reports » Broker Ratings » Oxford BioMedica plc 23.9% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc 23.9% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc using EPIC/TICKER code (LON:OXB) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Liberum Capital. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set a target price of 860 GBX on its stock. This would imply the analyst believes there is now a potential upside of 23.9% from today’s opening price of 694 GBX. Over the last 30 and 90 trading days the company share price has increased 58 points and increased 186 points respectively. The 1 year high for the stock price is 794.88 GBX while the 52 week low is 461.5 GBX.

Oxford BioMedica plc has a 50 day moving average of 618.86 GBX and the 200 Day Moving Average price is recorded at 656.76. There are currently 111,690,985 shares in issue with the average daily volume traded being 66,540. Market capitalisation for LON:OXB is £528,022,229 GBP.